News
Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...
21h
MedPage Today on MSNOnce-Monthly Oral PrEP Option Appears Safe, Tolerable in Adults at Low Risk of HIVThe investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to ...
The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...
13h
The Star on MSNResearchers uncover new treatment modes for older people with HIVExperts have proposed new treatment modes for older people with HIV. The new treatment does not cause the health-threatening ...
Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...
Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...
1d
AllAfrica on MSNUganda: Rise in HIV/Aids Cases Feared After U.S. Aid CutsScientists, researchers, policy makers and HIV/AIDS advocates at a meeting in Kigali, Rwanda, from July 13-17 for the 13th ...
The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with ...
The International AIDS Society (IAS) on Sunday called on President Trump to increase funding for AIDS research, warning that his proposed spending cuts could cause deaths. IAS president Linda-Gail ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results